EN DE
Watch Kwangdong Phar for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Kwangdong Phar (009290) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Kwangdong Phar stock KRW 7,026, price KRW 6,250, upside +12.4%, quality 39 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive KR · ISIN KR7009290008

KP Kwangdong Phar logo Some data Nov 7, 2026

Kwangdong Phar

009290 · KO
Speculative

The stock costs 11% less than our calculation considers fair.

Fair value 7,026 KRW · Undervalued
Low debt
Generates free cash flow
1.6% dividend yield · Well covered
Even on cautious assumptions the value is 11% above the price (6,965 KRW).
Mixed Growth (revenue 5y +5.9 %/yr in KRW)
Thin margins · 1.3% net margin (TTM)
Mixed vs. peers (7/14)
Some data
Quality 39/100
Narrow moat 27/100 · thin data
⚠ Dilution
Watch Kwangdong Phar for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

10,952 KRW 4,958 KRW Fair Value 7,026 KRW Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range 4,958 KRW – 10,952 KRW · fair‑value band 6,965 KRW – 8,804 KRW · the 6,250 KRW price screens below the 7,026 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow Kwangdong Phar in your weekly email

Every Wednesday you see whether Kwangdong Phar is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea.

Show moreShow less

It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins.

The company also offers supplements for low content vitamin, mineral or vital energy substance and quasi drugs.

In addition, it provides blackberry, ginger lonicerae flos, vita gold, and red ginseng gold drinks, as well as offers water, mixed drinks, tea drinks, and other drinks; and traditional health foods. The company offers its products through operation of TV, radio, and print advertising.

Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.

Stock analysis

Kwangdong Phar (009290) currently trades at 6,250 KRW, while our model-based Fair Value estimate is 7,026 KRW, implying the stock looks roughly 11% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of 16,126 KRW per share, and 18 of the 26 models we run sit above the 6,250 KRW price.

Bear case: the Dividend Discount group reads lowest at 983.62 KRW, and 8 of the 26 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 6,965 KRW (bear) to 8,804 KRW (bull), the price of 6,250 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 39/100 (below-average quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Kwangdong Phar reported revenue of 1.7T KRW in FY2025 versus 1.3T KRW in FY2021, a compound +5.5%/yr. Reported net income was 21.0B KRW in FY2025, compounding −3.3%/yr from FY2021.

Key figures

Market cap 310B KRW (≈ $229M) Micro · P/E ratio 14.1 · P/S ratio 0.18 · EPS (TTM) 439.07 KRW · Dividend yield 1.6% · Net margin 1.3% · Return on equity 3.5% · Return on assets (EBIT) 3.6% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (low confidence).

What moves the price

The share trades about 43% below its 52-week high and 19% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −1% fair-value upside, at 12%, 009290 screens cheaper than that median.

Fair Value models

Bear 6,965 KRW Fair Value 7,026 KRW Bull 8,804 KRW
Price 6,250 KRW · Upside +12.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (290.76 KRW per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 13,527 KRW 19,203 KRW 26,870 KRW 81
Growth DCF 13,499 KRW 18,746 KRW 25,507 KRW 79
Owner Earnings 9,112 KRW 12,662 KRW 17,458 KRW 77
All 26 models by family
DCF Models
FCF DCF 13,527 KRW 19,203 KRW 26,870 KRW 81
Owner Earnings 9,112 KRW 12,662 KRW 17,458 KRW 77
5Y Revenue Exit 9,748 KRW 13,376 KRW 17,889 KRW 73
5Y EBITDA Exit 12,009 KRW 17,729 KRW 24,422 KRW 75
5Y P/E Exit 10,207 KRW 14,261 KRW 18,513 KRW 72
10Y Revenue Exit 11,059 KRW 14,593 KRW 19,217 KRW 68
10Y EBITDA Exit 12,497 KRW 17,319 KRW 23,764 KRW 69
10Y P/E Exit 11,465 KRW 15,147 KRW 19,651 KRW 65
Earnings-Based
Graham-Dodd 2,869 KRW 10,271 KRW 13,838 KRW 64
Lynch FV 2,422 KRW 3,459 KRW 4,497 KRW 61
PEG = 1.0 2,422 KRW 3,459 KRW 4,497 KRW 57
EPV 5,022 KRW 5,445 KRW 5,794 KRW 74
Dividend Discount
Gordon GGM 585.18 KRW 1,019 KRW 1,364 KRW 68
DDM Multi-Stage 585.18 KRW 947.83 KRW 1,093 KRW 67
Multiples
P/E Multiple 6,961 KRW 9,281 KRW 11,602 KRW 63
P/S Multiple 5,379 KRW 7,172 KRW 8,965 KRW 58
P/B Multiple 6,104 KRW 8,138 KRW 10,173 KRW 55
EV/EBIT 5,048 KRW 7,703 KRW 10,358 KRW 65
EV/EBITDA 7,457 KRW 10,915 KRW 14,372 KRW 67
EV/Revenue 2,768 KRW 5,204 KRW 7,640 KRW 52
Asset-Based
NCAV (Graham) 702.21 KRW 1,064 KRW 1,330 KRW 54
Growth DCF
Growth DCF 13,499 KRW 18,746 KRW 25,507 KRW 79
Rev-Margin DCF 9,748 KRW 13,507 KRW 18,047 KRW 73
Economic Profit
Residual Income 8,195 KRW 8,266 KRW 8,836 KRW 76
ROIC Compounder 5,022 KRW 5,445 KRW 5,794 KRW 72
Growth Earnings
Growth-Adj P/E 4,769 KRW 6,812 KRW 8,856 KRW 67

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 39/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 41
How much profit the company makes from its sales and capital
Quality Growth 27
Are margins and returns getting better?
Cashflow 53
Do the profits arrive as real cash?
Financial strength 55
Debt, balance sheet and risk of trouble
Investment 66
Does it invest with discipline instead of growing at any price?
Low Volatility 54
How calm the share price moves, does not count
Price momentum 40
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 32
Distance to the 52-week high, does not count
New shares 7
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 66/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+1.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
Start year 2020 (pandemic). Over 10 years: +5.7% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.6%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−9.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−10.6%
Dividend (yield on the price)1.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−6.3% vs −4.8%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 2%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−3.0%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −5.0% a year for the price.

Watch 009290, get fair value alerts →

Compare Kwangdong Phar with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 625 stocks

Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 39 · Bottom 25%
Fair Value upside +12.4% · Above median
Profitability
Return on equity (12 months) 3.5% · Below median
Return on assets 1.6% · Below median
Net margin (12 months) 1.3% · Below median
Operating margin (12 months) 0.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 3.4% · Below median
Dividend yield (12 months) 1.6% · Below median
Balance sheet
Debt / equity 0.08× · Below median

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/E (12 months) 14.1× · Cheaper than median
P/B 0.47× · Cheapest 25%
P/S (12 months) 0.18× · Cheapest 25%
Price / free cash flow (fiscal year) 5.6× · Cheapest 25%
EV/EBITDA 4.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)50 · sector 35
FUTURE (revenue growth)17 · sector 25
PAST (return on equity)14 · sector 31
HEALTH (low debt)96 · sector 96
DIVIDEND (yield)32 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wilmar International Limited F34 2.97 SGD 4.93 SGD +66% vs 009290
Inner Mongolia Yili Industrial Group 600887 ¥31.45 ¥41.84 +33% vs 009290
The Kraft Heinz Company KHC $24.61 $29.20 +19% vs 009290
Foshan Haitian Flavouring and Food Company 603288 ¥35.78 ¥39.22 +10% vs 009290
General Mills, Inc GIS $35.51 $35.30 −1% vs 009290
Danone S.A BN €67.12 €50.65 −25% vs 009290
Nestlé S.A NESN CHF 85.85 CHF 59.51 −31% vs 009290
Kerry Group KRZ €98.00 €60.33 −38% vs 009290
Nestlé India Limited NESTLEIND ₹1,282 ₹724.74 −43% vs 009290
Yihai Kerry Arawana Holdings 300999 ¥26.21 ¥12.21 −53% vs 009290

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kwangdong Phar: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Kwangdong Phar Fair Value". https://www.fairvalue-calculator.com/stock/009290

Frequently asked questions

Is Kwangdong Phar (009290) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 7,026 KRW versus a price of 6,250 KRW, about +12% upside (undervalued).
What is the fair value of 009290?
Our model-based fair value for Kwangdong Phar is 7,026 KRW (as of Nov 7, 2026), built from audited fundamentals. The current price: 6,250 KRW.
What is the quality score of 009290?
Kwangdong Phar has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kwangdong Phar (009290)?
Our model-based price target is the fair value of 7,026 KRW (as of Nov 7, 2026) from 26 valuation models. Cautious scenario 6,965 KRW, optimistic scenario 8,804 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Kwangdong Phar stock forecast for 2026?
Our models put fair value at 7,026 KRW, about +12% upside versus a price of 6,250 KRW (undervalued). Cautious scenario 6,965 KRW, optimistic scenario 8,804 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Kwangdong Phar (009290)?
Kwangdong Phar reported trailing-twelve-month revenue of about 1.7T KRW (latest available figure, as of Nov 7, 2026).
Does Kwangdong Phar pay a dividend?
Kwangdong Phar currently shows a dividend yield of 1.60% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Kwangdong Phar (009290) and when is the ex-dividend date?
Kwangdong Phar pays a dividend of 100.00 KRW per share a year, a dividend yield of 1.6%. The last ex-dividend date was Mar 31, 2026. The payout ratio is 22.8% of earnings. Free cash flow covers the dividend 11.26 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Kwangdong Phar (009290)?
For today's price to be fair in a discounted-cash-flow model, Kwangdong Phar would have to grow free cash flow by -3.0 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.9 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of 009290 use?
Our models discount Kwangdong Phar at 11.6 %: a base by market capitalisation (micro), damped by beta 0.35, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kwangdong Phar that is -3.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Kwangdong Phar (009290) delivered so far?
Over the past 5 years revenue at Kwangdong Phar grew +5.9 % a year. The price currently implies free-cash-flow growth of -3.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kwangdong Phar (009290) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Kwangdong Phar (-3.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kwangdong Phar (009290)?
The free-cash-flow yield on the price is 18.03 %: that much free cash flow Kwangdong Phar produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kwangdong Phar (009290)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kwangdong Phar it is 7,026 KRW per share (as of Nov 7, 2026), against a price of 6,250 KRW. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Kwangdong Phar stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 009290 trades below its calculated fair value: price 6,250 KRW, fair value 7,026 KRW, a gap of about +12% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 009290?
No. The price is what the market pays today (6,250 KRW); the fair value is what the company's own numbers justify (7,026 KRW). For Kwangdong Phar the two are 776.47 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Kwangdong Phar worth?
The market values Kwangdong Phar at about 310B KRW (market capitalisation, as of Nov 7, 2026). Per share that is 6,250 KRW; our models calculate a fair value of 7,026 KRW per share.
What do the bullish and bearish scenarios say about 009290?
Our models span a range for Kwangdong Phar: cautious scenario 6,965 KRW, base 7,026 KRW, optimistic 8,804 KRW per share (as of Nov 7, 2026, price 6,250 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 009290?
Kwangdong Phar trades at a price-to-earnings ratio of 14.1 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 7,026 KRW is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 11.9. Other multiples: P/B 0.5, P/S 0.2, EV/EBITDA 4.1.
How solid is the balance sheet of Kwangdong Phar (009290)?
Balance-sheet figures for Kwangdong Phar (as of Nov 7, 2026): return on equity 3.5%, debt of 0.08 per unit of equity. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is 009290 from its 52-week high?
Kwangdong Phar trades at 6,250 KRW, about 43% below its 52-week high of 10,952 KRW and 19% above the low of 5,270 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 7,026 KRW is for.
Which stocks are comparable to Kwangdong Phar?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kwangdong Phar stock attractive at the current price?
The data as of Nov 7, 2026: price 6,250 KRW, calculated fair value 7,026 KRW (+12%), Quality Score 39/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 009290 calculated?
We run Kwangdong Phar through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 7,026 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Kwangdong Phar currently trades 11% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kwangdong Phar (009290)?
The closing price on Nov 6, 2026 was 6,250 KRW. Our model-based fair value is 7,026 KRW, about +12% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kwangdong Phar right now?
The price is below even our cautious bear case (6,965 KRW). The market is more pessimistic than our downside scenario. The price sits below our cautious bear case: the market assumes less than even our pessimistic scenario. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Kwangdong Phar

How large is the market capitalisation of Kwangdong Phar (009290)?
The market capitalisation of Kwangdong Phar is 310B KRW (≈ $229M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kwangdong Phar (009290)?
The price-to-sales ratio of Kwangdong Phar is 0.18 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kwangdong Phar (009290)?
Earnings per share at Kwangdong Phar are 439.07 KRW (price ÷ EPS = P/E 14.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Kwangdong Phar (009290)?
The dividend yield of Kwangdong Phar is 1.6% (payout 22.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Kwangdong Phar (009290)?
The net margin of Kwangdong Phar is 1.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kwangdong Phar (009290)?
The return on equity (ROE) of Kwangdong Phar is 3.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kwangdong Phar (009290)?
On an EBIT basis the return on assets of Kwangdong Phar is 3.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kwangdong Phar (009290)?
The operating margin of Kwangdong Phar is 0.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kwangdong Phar (009290)?
Revenue at Kwangdong Phar is growing +3.4% versus a year earlier (3y avg +5.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kwangdong Phar (009290)?
Earnings per share at Kwangdong Phar are growing −15.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Kwangdong Phar (009290) carry?
The net debt of Kwangdong Phar is 145B KRW (fiscal year 2025, ≈ 2.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Kwangdong Phar in the live analysis

One click puts Kwangdong Phar on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.